Investors’ data
Latest news
- July 10, 2008
Thallion Announces 2008 Second Quarter Results
- July 7, 2008
Notice of Thallion Pharmaceuticals Fiscal 2008 Second Quarter Conference Call
- June 26, 2008
Thallion receives health canada approval to initiate Phase II study for TLN-232 in metastatic melanoma patients- Company initiates Phase II study with its second oncology product -
Documentation
Stock Information
Thallion is listed on the Toronto Stock Exchange under the symbol "TLN".
| Symbol | TSX : TLN |
|---|---|
| Last trade | 0.28 |
| Open | 0.28 |
| Net change | 0.00 |
| High | 0.28 |
| Low | 0.28 |
| 52 week range | 0.16 - 0.90 |
| Volume | 6,350 |
| As of | 2008-08-27 10:08 EST |
| Note: Quotes are delayed. For informational purposes only. |
|